B
COMPANY PROFILE
BioSET
BioSET | Leading an Orthobiologic Revolution
Valuation
$25–50M
Last recorded · 2011
Headcount
2–5k
Current team size
Total funding
$10–50M
Disclosed equity funding
At a glance
- Founded
- 2001
- Headquarters
- Rockville, United States
- Sector
- Biotechnology
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Maryland Venture Fund
Boston Scientific
The Vertical Group- EVEDF Ventures
MB Venture Partners
Series B and later3 investors entered at this stage
- WMWestfield Capital Management
PTV Healthcare Capital
Saints Capital
Team profiled
3
named & role-tagged
Founders
Hidden — book a demo/100
quality score
Key operators
2
quality Hidden — book a demo/100
Potential founders
Hidden — book a demo
likely future founders
Startup mafia
Hidden — book a demo
alumni-founded startups
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioSET on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioSET on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.